10x Genomics (TXG) Interest & Investment Income (2018 - 2026)

10x Genomics has disclosed Interest & Investment Income across 9 years of filings, most recently posting $5.0 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $5.0 million, up 36.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.4 million (up 19.55% YoY), and the FY2025 annual result was $20.0 million, up 5.91% from the prior year.
• Interest & Investment Income came in at $5.0 million for Q1 2026 at 10x Genomics, down from $6.9 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $6.9 million in Q4 2025 to a low of $569000.0 in Q1 2022.
• The 5-year median for Interest & Investment Income is $4.3 million (2023), against an average of $4.0 million.
• Across the five-year window, Interest & Investment Income jumped 5644.9% in 2022 and declined 22.17% in 2025, its largest moves.
• 10x Genomics' Interest & Investment Income stood at $2.8 million in 2022, then soared by 63.98% to $4.6 million in 2023, then fell by 2.34% to $4.5 million in 2024, then jumped by 52.88% to $6.9 million in 2025, then fell by 27.25% to $5.0 million in 2026.
• The last three Interest & Investment Income figures came in at $5.0 million (Q1 2026), $6.9 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.